Figure 3
Impact of vaccination strategies: baseline scenario. Average number of administered vaccine per person per year (top row), distribution (2.5%, 25%, 75%, and 97.5% quantile and mean) of RSV incidence in infants (middle row), and in the general population (bottom row) as predicted by model simulation before vaccination (year 2014) and 1 and 10 years after vaccination (years 2015 and 2025) associated with the most effective vaccination strategies. Vaccine protection against infection is assumed to last 6 months and vaccination coverage is 100%. Vaccination of pregnant women is assumed to extend natural maternal protection of newborns from 4 to 6 months. The gray line reported throughout is used as a reference indicator for the no vaccination scenario.